Article Details
Retrieved on: 2025-10-02 20:08:55
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Key Points. Xeris Biopharma's stock reached a new 12-month high, trading at $8.36 during mid-day, reflecting strong market interest. Analysts have ...
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here